Class II peptide multimers: promise for type 1A diabetes?
- 1 April 2002
- journal article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (4), 344-345
- https://doi.org/10.1038/ni0402-344
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide–MHC class II chimeraNature Immunology, 2002
- Peptide and Major Histocompatibility Complex–Specific Breaking of Humoral Tolerance to Native Insulin With the B9-23 Peptide in Diabetes-Prone and Normal MiceDiabetes, 2001
- Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetesNature Immunology, 2001
- Direct enumeration ofBorrelia-reactive CD4 T cellsex vivoby using MHC class II tetramersProceedings of the National Academy of Sciences, 2000
- HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive CellsThe Journal of Immunology, 2000
- Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetesProceedings of the National Academy of Sciences, 2000
- MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigenJournal of Clinical Investigation, 1999
- Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: Acetylcholine receptor peptide complexesJournal of Autoimmunity, 1995
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.Proceedings of the National Academy of Sciences, 1991